Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism

HP Brunner-La Rocca, G Vaddadi, MD Esler - Journal of the American …, 1999 - jacc.org
One possible intervention to interrupt the deleterious effects of the renin-angiotensin system
is suppression of angiotensin II (Ang II) formation by inhibition of angiotensin-converting …

Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat

MP Ocaranza, I Godoy, JE Jalil, M Varas… - …, 2006 - Am Heart Assoc
The early and long-term effects of coronary artery ligation on the plasma and left ventricular
angiotensin-converting enzyme (ACE and ACE2) activities, ACE and ACE2 mRNA levels …

Functional and biochemical analysis of angiotensin II–forming pathways in the human heart

A Wolny, JP Clozel, J Rein, P Mory, P Vogt… - Circulation …, 1997 - Am Heart Assoc
Blockade of the renin-angiotensin system by inhibition of angiotensin-converting enzyme
(ACE) is beneficial for the treatment of hypertension and congestive heart failure. However, it …

Targeting the ACE2–Ang-(1–7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure

M Iwata, RT Cowling, SJ Yeo, B Greenberg - Journal of molecular and …, 2011 - Elsevier
Fibroblasts play a pivotal role in cardiac remodeling and the development of heart failure
through the deposition of extra-cellular matrix (ECM) proteins and also by affecting …

Tissue angiotensin II system in the human heart

H Urata, S Hoffmann, D Ganten - European heart journal, 1994 - academic.oup.com
Several intervention studies with angiotensin I converting enzyme (ACE) inhibitors have
demonstrated a remarkable improvement in the treatment of patients with primary …

Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade

M Igase, K Kohara, T Nagai, T Miki… - Hypertension Research, 2008 - nature.com
Abstract Angiotensin converting enzyme 2 (ACE2), a newly recognized homolog of ACE that
converts angiotensin II (Ang II) to angiotensin-1–7 (Ang-(1–7)), is found in vascular smooth …

Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure

LB Arendse, AHJ Danser, M Poglitsch, RM Touyz… - Pharmacological …, 2019 - ASPET
Despite the success of renin-angiotensin system (RAS) blockade by angiotensin-converting
enzyme (ACE) inhibitors and angiotensin II type 1 receptor (AT1R) blockers, current …

Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure

CAJ Farquharson, AD Struthers - Journal of the American College of …, 2002 - jacc.org
OBJECTIVES This study was designed to fully characterize vascular tissue angiotensin I
(AI)/angiotensin II (AII) conversion changes over time in vivo in humans during chronic …

Angiotensin‐converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease

C Tikellis, MC Thomas - International journal of peptides, 2012 - Wiley Online Library
Angiotensin‐converting enzyme 2 (ACE2) shares some homology with angiotensin‐
converting enzyme (ACE) but is not inhibited by ACE inhibitors. The main role of ACE2 is the …

[HTML][HTML] Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice

SB Gurley, A Allred, TH Le, R Griffiths… - The Journal of …, 2006 - Am Soc Clin Investig
The carboxypeptidase ACE2 is a homologue of angiotensin-converting enzyme (ACE). To
clarify the physiological roles of ACE2, we generated mice with targeted disruption of the …